» Articles » PMID: 8598206

An Antagonist-insensitive P2X Receptor Expressed in Epithelia and Brain

Overview
Journal EMBO J
Date 1996 Jan 2
PMID 8598206
Citations 120
Authors
Affiliations
Soon will be listed here.
Abstract

A cDNA was cloned which encodes a new ATP-gated ion channel (P2X4 receptor). ATP induces a cationic current in HEK293 cells transfected with the P2X4 receptor. However, the current is almost completely insensitive to antagonists effective at other P2X receptors. Sensitivity to two of these antagonists (pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid and pyridoxal 5-phosphate) is restored by replacement of Glu249 by lysine, which occurs at the equivalent position in P2X1 and P2X2 receptors. P2X4 RNA is found by in situ hybridization in the brain, peripheral ganglia and epithelia including serosal cells of salivary glands. Recordings from rat submandibular gland cells showed ATP-induced currents that are also insensitive to antagonists. These results define a further member of P2X receptor family, and they identify an amino acid residue involved in antagonist binding. They also introduce a new phenotype for ATP responses at P2X receptors--insensitivity to currently known antagonists.

Citing Articles

Structural insights into the orthosteric inhibition of P2X receptors by non-ATP analog antagonists.

Sheng D, Yue C, Jin F, Wang Y, Ichikawa M, Yu Y Elife. 2024; 12.

PMID: 38578670 PMC: 10997329. DOI: 10.7554/eLife.92829.


Purinoceptors in the Central Nervous System.

Dunwiddie T, Abbracchio M, Bischofberger N, Brundege J, Buell G, Collo G Drug Dev Res. 2024; 39(3-4):361-370.

PMID: 38283105 PMC: 10821783. DOI: 10.1002/(sici)1098-2299(199611/12)39:3/4<361::aid-ddr17>3.0.co;2-4.


Structural insights into the allosteric inhibition of P2X4 receptors.

Shen C, Zhang Y, Cui W, Zhao Y, Sheng D, Teng X Nat Commun. 2023; 14(1):6437.

PMID: 37833294 PMC: 10575874. DOI: 10.1038/s41467-023-42164-y.


Migraine signaling pathways: purine metabolites that regulate migraine and predispose migraineurs to headache.

Biringer R Mol Cell Biochem. 2023; 478(12):2813-2848.

PMID: 36947357 DOI: 10.1007/s11010-023-04701-7.


The P2X4 Receptor: Cellular and Molecular Characteristics of a Promising Neuroinflammatory Target.

Sophocleous R, Ooi L, Sluyter R Int J Mol Sci. 2022; 23(10).

PMID: 35628550 PMC: 9147237. DOI: 10.3390/ijms23105739.


References
1.
Kasakov L, Burnstock G . The use of the slowly degradable analog, alpha, beta-methylene ATP, to produce desensitisation of the P2-purinoceptor: effect on non-adrenergic, non-cholinergic responses of the guinea-pig urinary bladder. Eur J Pharmacol. 1982; 86(2):291-4. DOI: 10.1016/0014-2999(82)90330-2. View

2.
Fenwick E, Marty A, Neher E . A patch-clamp study of bovine chromaffin cells and of their sensitivity to acetylcholine. J Physiol. 1982; 331:577-97. PMC: 1197770. DOI: 10.1113/jphysiol.1982.sp014393. View

3.
Sneddon P, Westfall D . Pharmacological evidence that adenosine triphosphate and noradrenaline are co-transmitters in the guinea-pig vas deferens. J Physiol. 1984; 347:561-80. PMC: 1199464. DOI: 10.1113/jphysiol.1984.sp015083. View

4.
Dunn P, BLAKELEY A . Suramin: a reversible P2-purinoceptor antagonist in the mouse vas deferens. Br J Pharmacol. 1988; 93(2):243-5. PMC: 1853806. DOI: 10.1111/j.1476-5381.1988.tb11427.x. View

5.
Sasaki T, Gallacher D . Extracellular ATP activates receptor-operated cation channels in mouse lacrimal acinar cells to promote calcium influx in the absence of phosphoinositide metabolism. FEBS Lett. 1990; 264(1):130-4. DOI: 10.1016/0014-5793(90)80782-e. View